相关实验视频
Updated: Jan 8, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.7K
儿童肥胖和男性青春期发展之间的关系:系统性审查和元分析
1Department of Pediatrics, Mianzhu People's Hospital, Mianzhu, China.
Frontiers in endocrinology
|December 15, 2025
概括
超重和肥胖的男孩在青春期出现早期丸扩大和阴毛发育的风险增加. 这些体重条件显著影响男性青春期的进展和时间.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 生殖健康 生殖健康
- 公共卫生 公共卫生
背景情况:
- 儿童超重和肥胖是全球健康问题.
- 青春期涉及到男孩的显著生理变化.
- 了解超重对青春期发育的影响至关重要.
研究的目的:
- 分析与青春期男孩超重和肥胖相关的风险.
- 研究超重和肥胖男孩的生理发育差异,特别是丸扩大和阴毛生长.
主要方法:
- 按照PRISMA 2020指南进行系统的文献搜索.
- 包括12个前性队列研究.
- 使用STATA 17.0和Review Manager (RevMan 5.4) 的统计分析.
主要成果:
- 超重和肥胖的男孩面临着早期丸扩大 (RR 1.38-1.43) 和早期发病 (MD -0.23) 的更高风险.
- 发现了显著的区域差异 (美国,亚太地区) 和与年龄相关的影响 (年龄超过6岁).
- 超重和肥胖的男孩表现出早期阴毛发育 (RR 1.24-1.42) 和早期发病 (MD -0.38) 的风险增加.
- 肥胖和正常体重男孩之间没有观察到峰值身高速度的显著差异.
结论:
- 超重和肥胖显著影响男性青春期,特别是早期的丸和阴毛发育.
- 这些发现凸显了监测超重/肥胖男孩青春期进展的必要性.
相关概念视频
Signs of Puberty
1.3K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.3K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
159
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Drug Dosing: Obese Patients
198
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Nature and Nurture
22.1K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.1K

